• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 EXPRESS FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 EXPRESS FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number RF400F
Device Problems Migration or Expulsion of Device (1395); Difficult to Remove (1528); Detachment of Device or Device Component (2907)
Patient Problems Chest Pain (1776); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 04/16/2019
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately ten years post filter deployment chest x-ray revealed there linear radiopaque foreign body measuring 2.9 cm in length projected upon the heart at the left base medially on the frontal radiograph and anteriorly on the lateral radiograph, therefore this may be within the right ventricle.This was likely a fragment from the patient's inferior vena cava filter which was embolized.The computed tomography (ct) revealed metallic foreign body in right ventricle likely represented fractured leg from inferior vena cava filter.The patient endorsed cough and pain along ribs.The transthoracic echocardiogram (tte) showed that a trace pericardial effusion appeared present and trace mitral regurgitation.There were no echocardiographic indications of cardiac tamponade.Subsequent computed tomography (ct) on the following day revealed unchanged position of a fractured/migrated inferior vena cava filter prong.The tip of the prone appeared to be embedded within the intraventricular septum near the apex, possibly extending into the left ventricular apical lumen.Eventually a day later, computed tomography (ct) revealed fractured inferior vena cava filter with 2 of the struts embolized to the heart apex and hepatic segment 6 within the accessory inferior right hepatic lobe draining vein.No deep vein thrombosis within the inferior vena cava or imaged iliac/femoral veins was found.Therefore, the investigation is confirmed for the filter limb detachment.However the investigation is inconclusive for the alleged the filter migration and retrieval difficulties.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 03/2011).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the entire filter migrated to heart and detached.The detached strut retained in right ventricle and liver.The device was removed after an attempted but unsuccessful percutaneous removal procedure.The detached strut has not been removed after an attempted but unsuccessful percutaneous removal procedure.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 EXPRESS FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key10060847
MDR Text Key191102179
Report Number2020394-2020-03405
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K080668
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 05/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF400F
Device Lot NumberGFSC1037
Was Device Available for Evaluation? No
Date Manufacturer Received04/23/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/28/2008
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
EXCEDRIN MIGRAINE, VITAMIN B-12 AND HERB-A-LAX; EXCEDRIN, ANXIOLYTIC, ALFALFA AND VITAMIN-C; TYLENOL, COLACE, MELATONIN, ZOFRAN AND MIRALAX; ZINC PO, NYQUIL PO, CEPACOL, TUMS AND SENOKOT
Patient Outcome(s) Other; Required Intervention;
Patient Age58 YR
Patient Weight57
-
-